Annual report [Section 13 and 15(d), not S-K Item 405]

Balance Sheets

v3.25.1
Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 4,091,990 $ 6,989,424
Acquired patents, net 1,779 5,391
Total assets 4,093,769 6,994,815
Current liabilities    
Accounts payable & accrued interest 1,177,536 256,317
Deferred compensation 306,281  
Unreimbursed expenses 75,916 38,089
Total current liabilities 1,559,733 294,406
Total liabilities 1,559,733 294,406
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 13,152,729 and 12,848,165 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 13,153 12,848
Additional paid-in capital 68,674,261 57,052,130
Accumulated deficit (66,153,378) (50,364,569)
Total stockholders’ equity 2,534,036 6,700,409
Total liabilities and stockholders’ equity $ 4,093,769 $ 6,994,815